Sustainability & Climate

At Milan Design Week, De' Longhi Group fused coffee with high art and design, proving your morning brew can be a masterpiece of daily life.

Medical tech giant Convatec unveils a new arsenal of advanced wound care solutions, using nitric oxide and placental tech to combat hard-to-heal injuries.

California date brand Joolies launches a game-changing sour candy made from dates, exclusively at Sprouts. It's a sweet and sour bet on clean eating.

As FDA rules on peptides shift, a new AI platform aims to give doctors clarity, separating solid science from speculation in the booming longevity market.

Packaging giant Novolex appoints Marco Hilty to lead a key unit, signaling a major push for international expansion and sustainable innovation.

The largest-ever study on school phone bans confirms huge drops in phone use and improved student well-being, but the impact on test scores is more complex.

With a novel 'NewCo' model and key partnerships, Banyan BioInnovations aims to de-risk and accelerate clinical-stage drugs past the funding valley of death.

A new report reveals a dramatic shift in Alzheimer's drug development, with 75% of trials now targeting pathways beyond amyloid for a new age of treatment.

Experts predict a hyperactive hurricane season. Learn why the threat is rising and how to protect your property before the first storm makes landfall.

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.

A new partnership offers employees interest-free financing for out-of-pocket medical costs, tackling a key barrier to care and boosting employer benefits.

Following a record 10.7 million visitors, The Palm Beaches are unveiling a wave of new hotels, restaurants, and cultural hubs. But can the boom be sustained?

A biotech firm is making waves with a non-viral, redosable gene delivery system showing promise for DMD and hemophilia, challenging the industry's reliance on viruses.

Ottobock and Angel City Sports expand their partnership, using advanced tech and community events to build momentum for the LA28 Paralympic Games.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.

The healthy meal company is betting on 'better-for-you' comfort food with a QVC debut of classic pizzas, aiming to redefine the frozen food market.

HealthVerity's acquisition of Symphony Health unites clinical and commercial data, promising to shatter industry silos and accelerate medical breakthroughs.

Following a key Gartner recognition, Aegis Software is integrating digital twins and AI to move factories from reactive execution to predictive intelligence.

Known for intense Takis, Barcel USA is diversifying with Mi Tierra, a new brand targeting families with simple ingredients and authentic Mexican flavors.

Following a landmark FDA approval and strong earnings, Axsome must convince investors its momentum can translate into long-term profitability and leadership.